Peripheral arterial occlusions: local low-dose thrombolytic therapy with recombinant
tissue-type plasminogen activator (rt-PA).
An endothelial storage granule for
tissue-type plasminogen activator.
The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast acting inhibator of
tissue-type plasminogen activator after trauma.
On the role of C1-inhibitor as inhibitor of
tissue-type plasminogen activator in human plasma.
NASDAQ: BIPL) today announced the results of a Harvard Medical School study demonstrating that plasma levels of
tissue-type plasminogen activator (t-PA) may be an even more important indicator of risk for future heart attack than cholesterol.
Blood collection and handling procedures for assessment of
tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1).
Of the two plasminogen activators known,
tissue-type plasminogen activator is involved mainly in intravascular fibrinolysis, whereas urokinase plasminogen activator (uPA)5 is most important in pericellular matrix degradation processes, such as in wound healing, inflammatory disease, and cancer invasion (1, 2).
In one clinical study, low
tissue-type plasminogen activator activity and higher PAI-1 concentrations were observed in survivors of myocardial infarction compared with healthy age-matched controls (58).
